NAMS

18.4105.64%
MP

Matthew Philippe

Executive VP & Head of Investor Relations

Mr. Matthew Philippe, also known as Matt, is Executive VP & Head of Investor Relations of NewAmsterdam Pharma Company N. V. from April 2023. Mr. Philippe joined the NewAmsterdam Pharma Company N. V. in April 2023 with nearly healthcare investing and corporate finance experience. From 2019 through 2023, he was a portfolio Manager at Schonfeld Strategic Advisors, running a fundamental healthcare portfolio. Between 2015 and 2019, he was an Equities Analyst leading the global healthcare initiative at Karst Peak Capital. From 2014-2015, he was Vice President of medical supply and device research at Deutsche Bank in New York. Prior to that, he was an Analyst at Avet Capital Management, a long-short equity fund focused exclusively on the healthcare sector. In addition, he worked at Numoda Capital Innovations, a private equity and venture capital firm investing in healthcare services, biotechnology and device companies. He began his healthcare corporate finance career with the Global Healthcare Group at C. E. Unterberg Towbin, which was acquired by Collins Stewart during his tenure. He received his MBA from Columbia Business School in 2013 and received his BS in biology, BS in finance, BA in spanish and minors in chemistry and biomedical sciences from Colorado State University, where he graduated as a University Honors Scholar in 2005.

Positions